162 related articles for article (PubMed ID: 8588238)
1. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of rapamycin.
Yatscoff RW
Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.
Trepanier DJ; Gallant H; Legatt DF; Yatscoff RW
Clin Biochem; 1998 Jul; 31(5):345-51. PubMed ID: 9721433
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
Yatscoff RW; LeGatt DF; Kneteman NM
Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
[TBL] [Abstract][Full Text] [Related]
5. Role of therapeutic drug monitoring of rapamycin.
Kahan BD; Napoli KL
Transplant Proc; 1998 Aug; 30(5):2189-91. PubMed ID: 9723436
[No Abstract] [Full Text] [Related]
6. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients.
Brattström C; Säwe J; Tydén G; Herlenius G; Claesson K; Zimmerman J; Groth CG
Ther Drug Monit; 1997 Aug; 19(4):397-406. PubMed ID: 9263380
[TBL] [Abstract][Full Text] [Related]
9. Determination of rapamycin in whole blood by HPLC.
Svensson JO; Brattström C; Säwe J
Ther Drug Monit; 1997 Feb; 19(1):112-6. PubMed ID: 9029760
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of rapamycin: single-dose studies in the rabbit.
Honcharik N; Fryer J; Yatscoff R
Ther Drug Monit; 1992 Dec; 14(6):475-8. PubMed ID: 1485369
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of sirolimus in kidney transplant patients.
Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
[TBL] [Abstract][Full Text] [Related]
12. Blood distribution of rapamycin.
Yatscoff R; LeGatt D; Keenan R; Chackowsky P
Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Johnson EM; Zimmerman J; Duderstadt K; Chambers J; Sorenson AL; Granger DK; Almond PS; Fryer Jp; Leventhal JR; Scarola J; Matas AJ; Canafax DM
Transplant Proc; 1996 Apr; 28(2):987. PubMed ID: 8623490
[No Abstract] [Full Text] [Related]
14. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.
Napoli KL; Kahan BD
Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
[No Abstract] [Full Text] [Related]
16. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.
Napoli KL; Kahan BD
J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration.
Zimmerman JJ; Kahan BD
J Clin Pharmacol; 1997 May; 37(5):405-15. PubMed ID: 9156373
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic monitoring of cyclosporine, FK-506, and rapamycin.
Yatscoff RW; Shaw LM
Ther Drug Monit; 1992 Aug; 14(4):267-8. PubMed ID: 1381530
[No Abstract] [Full Text] [Related]
19. Pharmacodynamic monitoring of immunosuppressive drugs.
Yatscoff RW; Aspeslet LJ; Gallant HL
Clin Chem; 1998 Feb; 44(2):428-32. PubMed ID: 9474055
[TBL] [Abstract][Full Text] [Related]
20. Current opinions on therapeutic drug monitoring of immunosuppressive drugs.
Shaw LM; Holt DW; Keown P; Venkataramanan R; Yatscoff RW
Clin Ther; 1999 Oct; 21(10):1632-52; discussion 1631. PubMed ID: 10566561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
